Classification of patients with prostate cancer into risk groups has been based on patient characteristics such as pretreatment prostate-specific antigen levels and Gleason score; however, it is ...
The Central Drugs Standard Control Organisation (CDSCO) has announced risk classification of 119 medical devices pertaining to radiotherapy under the Medical Devices Rules (MDR), 2017, as part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback